✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Mangalam Drugs And Organics Ltd.

MANGALAM

Market Cap
₹129 Cr.
P/E
19.13

Mangalam Drugs And Organics Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
129 Cr
PE
PE
19.13
Prom Holding
Prom Holding
50.30 %
ROE (%)
ROE (%)
-6.68
ROCE (%)
ROCE (%)
1.68
Div Yield (%)
Div Yield (%)
-
Sales
Sales
318 Cr
OPM (%)
OPM (%)
11.26 %
Debt to Equity
Debt to Equity
0.70
View more
Edit Ratio's
About
Mangalam Drugs and Organics Limited is an India-based company engaged in the manufacturing of … Read more
Low
70
52W Range
High
145
  • Mangalam Drugs&Org.
  • Smruthi Organics
  • Tyche Inds

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates
Custom financial statementNew
Edit rows
Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Raw Material Break-Up

Operational Metrics

    locked
    Select a Metric
    • Advertisement Spend as a % of Total Sales (%)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    FAQs on Mangalam Drugs And Organics Ltd. Business

    Mangalam Drugs and Organics Limited, an India-based company, specializes in manufacturing various chemicals including active pharma ingredients, perfumery, disperse dye intermediates, bulk drugs, and bulk drugs intermediates.

    Mangalam Drugs&Org. major competitors are Smruthi Organics, Tyche Inds, Bal Pharma, Lasa Supergenerics, Everest Organics, SMS Lifesciences, Nectar Lifesciences.
    Market Cap of Mangalam Drugs&Org. is ₹128 Crs.
    While the median market cap of its peers are ₹162 Crs.

    Mangalam Drugs&Org. seems to be less financially stable compared to its competitors.
    Altman Z score of Mangalam Drugs&Org. is 2.06 and is ranked 5 out of its 8 competitors.

    View FAQ's On Shareprice
    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release
    Investor Presentation Mar Jun Dec
    Conference Call
    Conference Call SummaryCon Call Summary
    Discussions & Analysis
    Mangalam Drugs And Organics Ltd.
    View the discussion on ValuePickr
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material